About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study Evaluating HKI-272 Administered to Healthy Subjects

NCT00366600·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Puma Biotechnology, Inc.

Age

18–50

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Healthy

The record

StatusCompleted

PhasePhase 1

Taking part56

StartedJul 2006

UpdatedSep 11, 2017

Conditions

Where1

Northwest Kinetics
Tacoma, Washington, United States

Clareo Health | Study Evaluating HKI-272 Administered to Healthy Subjects